NASDAQ: JBIO
Jade Biosciences Inc Stock Ownership - Who owns Jade Biosciences?

Insider buying vs selling

Have Jade Biosciences Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Fairmount Funds Management LLCDirector2025-10-061,333,126$9.14
$12.18MBuy
Tom FrohlichChief Executive Officer2025-05-166,000$7.40
$44.40kBuy

1 of 1

JBIO insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when JBIO insiders and whales buy or sell their stock.

JBIO Shareholders

What type of owners hold Jade Biosciences Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Fmr LLC10.63%4,888,781$72.55MInstitution
Fairmount Funds Management LLC9.90%4,553,494$67.57MInsider
Maha Katabi8.17%3,758,686$55.78MInsider
Sofinnova Venture Partners X LP8.17%3,758,686$55.78MInsider
Fairmount Funds Management LLC7.00%3,220,368$47.79MInstitution
Vr Adviser LLC7.00%3,220,364$47.79MInstitution
Atlas Venture Fund XII LP5.06%2,327,909$34.55MInsider
Deep Track Capital LP4.96%2,279,892$33.83MInstitution
Blackrock Inc4.67%2,150,203$31.91MInstitution
Cormorant Asset Management LP4.41%2,030,691$30.14MInsider

1 of 3

JBIO vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
JBIO62.53%37.47%Net BuyingNet Buying
RGNX76.78%23.22%Net SellingNet Selling
FULC65.03%34.97%Net SellingNet Selling
CGEM55.51%44.49%Net BuyingNet Buying
VALN3.25%0.00%

Jade Biosciences Stock Ownership FAQ

Who owns Jade Biosciences?

Jade Biosciences (NASDAQ: JBIO) is owned by 68.73% institutional shareholders, 41.18% Jade Biosciences insiders, and 0.00% retail investors. Fairmount Funds Management LLC is the largest individual Jade Biosciences shareholder, owning 4.55M shares representing 9.90% of the company. Fairmount Funds Management LLC's Jade Biosciences shares are currently valued at $68.21M.

If you're new to stock investing, here's how to buy Jade Biosciences stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.